REQUEST A DEMO
Total
USD $0.00
Search more companies

South Star Drug, Inc. (Philippines)

Main Activities: Pharmacies and Drug Stores
Full name: South Star Drug, Inc. Profile Updated: March 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

South Star Drug, Inc. is an enterprise in Philippines, with the main office in Quezon City. The enterprise currently operates in the Pharmacies and Drug Stores sector. It was established on November 23, 2003. It currently has a total number of 4,101 (2024) employees. In 2024, the company reported a net sales revenue increase of 9.46%. During that time, South Star Drug, Inc.’s total assets grew by 14.73%. South Star Drug, Inc.’s net profit margin decreased by 0.28% in 2024.

Headquarters
No. 110 E. Rodriguez Jr. Avenue, Bagumbayan
Quezon City; National Capital Region; Postal Code: 1110

Contact Details: Purchase the South Star Drug, Inc. report to view the information.

Basic Information
Total Employees:
Purchase the South Star Drug, Inc. report to view the information.
Financial Auditors:
Purchase the South Star Drug, Inc. report to view the information.
Incorporation Date:
November 23, 2003
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chairman and Director
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
Subsidiaries
Rose Pharmacy, Incorporated
Company Performance
Financial values in the chart are available after South Star Drug, Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PHP. Absolute financial data is included in the purchased report.
Net sales revenue
9.46%
Total Operating Revenue
10.24%
Operating Profit
4.52%
EBITDA
4.52%
Net Profit/Loss for the Period
0.46%
Total Assets
14.73%
Total Equity
4.01%
Operating Profit Margin
-0.25%
Net Profit Margin
-0.28%
Return on Equity (ROE)
-0.27%
Debt / Equity
12.09%
Quick Ratio
0%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?